Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 15.66
(-1.39%)
CNY 15.66
(-1.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 522.91 Million CNY | 30.69% |
| 2022 | 392.95 Million CNY | 34.58% |
| 2021 | 294.2 Million CNY | 54.57% |
| 2020 | 183.99 Million CNY | 49.37% |
| 2019 | 102.98 Million CNY | 15.66% |
| 2018 | 79.84 Million CNY | -8.92% |
| 2017 | 101.92 Million CNY | -24.48% |
| 2016 | 154.06 Million CNY | 6.97% |
| 2015 | 149.15 Million CNY | -1.79% |
| 2014 | 155.28 Million CNY | 28.98% |
| 2013 | 120.03 Million CNY | 29.55% |
| 2012 | 92.27 Million CNY | 23.64% |
| 2011 | 73.7 Million CNY | 20.33% |
| 2010 | 62.49 Million CNY | 21.07% |
| 2009 | 41.22 Million CNY | 47.64% |
| 2008 | 24.86 Million CNY | 15.22% |
| 2007 | 21.86 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 162.78 Million CNY | 5.89% |
| 2024 Q3 | 152.97 Million CNY | -22.63% |
| 2024 Q1 | 175.36 Million CNY | 44.4% |
| 2023 Q1 | 115.61 Million CNY | 34.95% |
| 2023 Q4 | 115.22 Million CNY | 5.72% |
| 2023 Q3 | 108.98 Million CNY | -7.42% |
| 2023 Q2 | 117.72 Million CNY | 1.83% |
| 2023 FY | - CNY | 30.69% |
| 2022 Q1 | 85.66 Million CNY | 41.68% |
| 2022 FY | - CNY | 34.58% |
| 2022 Q4 | 85.66 Million CNY | 1.32% |
| 2022 Q3 | 84.55 Million CNY | 1.38% |
| 2022 Q2 | 83.39 Million CNY | -2.64% |
| 2021 FY | - CNY | 54.57% |
| 2021 Q4 | 60.46 Million CNY | -0.76% |
| 2021 Q3 | 60.92 Million CNY | 1.56% |
| 2021 Q2 | 59.98 Million CNY | 2.5% |
| 2021 Q1 | 58.52 Million CNY | 27.07% |
| 2020 FY | - CNY | 49.37% |
| 2020 Q3 | 42.24 Million CNY | 26.23% |
| 2020 Q1 | 16.77 Million CNY | -15.18% |
| 2020 Q2 | 33.46 Million CNY | 99.43% |
| 2020 Q4 | 46.05 Million CNY | 9.04% |
| 2019 Q2 | 21.74 Million CNY | -4.39% |
| 2019 FY | - CNY | 15.66% |
| 2019 Q3 | 16.59 Million CNY | -23.71% |
| 2019 Q4 | 19.78 Million CNY | 19.22% |
| 2019 Q1 | 22.74 Million CNY | 42.14% |
| 2018 Q3 | -3.56 Million CNY | -110.21% |
| 2018 FY | - CNY | -8.92% |
| 2018 Q2 | 34.91 Million CNY | 60.28% |
| 2018 Q4 | 16 Million CNY | 548.83% |
| 2018 Q1 | 21.78 Million CNY | -23.02% |
| 2017 Q4 | 28.3 Million CNY | 754.08% |
| 2017 Q3 | -4.32 Million CNY | -107.77% |
| 2017 Q1 | 29.92 Million CNY | -44.52% |
| 2017 FY | - CNY | -24.48% |
| 2017 Q2 | 55.69 Million CNY | 86.14% |
| 2016 Q2 | 55.4 Million CNY | 91.82% |
| 2016 FY | - CNY | 6.97% |
| 2016 Q4 | 53.93 Million CNY | 1342.68% |
| 2016 Q1 | 28.88 Million CNY | -24.27% |
| 2016 Q3 | 3.73 Million CNY | -93.25% |
| 2015 Q4 | 38.14 Million CNY | 69.62% |
| 2015 FY | - CNY | -1.79% |
| 2015 Q3 | 22.48 Million CNY | -49.61% |
| 2015 Q2 | 44.62 Million CNY | 52.31% |
| 2015 Q1 | 29.29 Million CNY | -47.56% |
| 2014 Q4 | 55.87 Million CNY | 95.34% |
| 2014 Q3 | 28.6 Million CNY | -30.63% |
| 2014 FY | - CNY | 28.98% |
| 2014 Q1 | 18.61 Million CNY | -56.47% |
| 2014 Q2 | 41.23 Million CNY | 121.53% |
| 2013 Q4 | 42.76 Million CNY | 99.05% |
| 2013 FY | - CNY | 29.55% |
| 2013 Q3 | 21.48 Million CNY | -38.4% |
| 2013 Q2 | 34.87 Million CNY | 171.53% |
| 2013 Q1 | 12.84 Million CNY | -62.62% |
| 2012 Q4 | 34.36 Million CNY | 130.55% |
| 2012 Q3 | 14.9 Million CNY | -11.16% |
| 2012 Q2 | 16.77 Million CNY | 42.42% |
| 2012 FY | - CNY | 23.64% |
| 2012 Q1 | 11.78 Million CNY | -61.47% |
| 2011 Q3 | 12.52 Million CNY | -49.05% |
| 2011 Q1 | 6.52 Million CNY | -66.97% |
| 2011 Q2 | 24.58 Million CNY | 276.98% |
| 2011 Q4 | 30.57 Million CNY | 144.17% |
| 2011 FY | - CNY | 20.33% |
| 2010 FY | - CNY | 21.07% |
| 2010 Q4 | 19.74 Million CNY | 63.06% |
| 2010 Q2 | 21.04 Million CNY | 451.97% |
| 2010 Q3 | 12.1 Million CNY | -42.49% |
| 2010 Q1 | 3.81 Million CNY | 0.0% |
| 2009 FY | - CNY | 47.64% |
| 2008 FY | - CNY | 15.22% |
| 2007 FY | - CNY | 0.0% |